Suppr超能文献

召唤脾酪氨酸激酶(SYK):SYK在癌症中作为肿瘤促进因子和肿瘤抑制因子的双重作用

Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer.

作者信息

Krisenko Mariya O, Geahlen Robert L

机构信息

Department of Medicinal Chemistry and Molecular Pharmacology, Purdue Center for Cancer Research, Purdue University, West Lafayette, IN 47907, United States.

Department of Medicinal Chemistry and Molecular Pharmacology, Purdue Center for Cancer Research, Purdue University, West Lafayette, IN 47907, United States.

出版信息

Biochim Biophys Acta. 2015 Jan;1853(1):254-63. doi: 10.1016/j.bbamcr.2014.10.022. Epub 2014 Nov 4.

Abstract

SYK (spleen tyrosine kinase) is well-characterized in the immune system as an essential enzyme required for signaling through multiple classes of immune recognition receptors. As a modulator of tumorigenesis, SYK has a bit of a schizophrenic reputation, acting in some cells as a tumor promoter and in others as a tumor suppressor. In many hematopoietic malignancies, SYK provides an important survival function and its inhibition or silencing frequently leads to apoptosis. In cancers of non-immune cells, SYK provides a pro-survival signal, but can also suppress tumorigenesis by restricting epithelial-mesenchymal transition, enhancing cell-cell interactions and inhibiting migration.

摘要

脾酪氨酸激酶(SYK)在免疫系统中已得到充分表征,是多种免疫识别受体信号传导所需的一种关键酶。作为肿瘤发生的调节因子,SYK的名声有点“分裂”,在某些细胞中起肿瘤促进作用,而在另一些细胞中则起肿瘤抑制作用。在许多血液系统恶性肿瘤中,SYK发挥重要的生存功能,抑制或沉默它常常会导致细胞凋亡。在非免疫细胞癌中,SYK提供促生存信号,但也可通过限制上皮-间质转化、增强细胞间相互作用和抑制迁移来抑制肿瘤发生。

相似文献

3
The Syk tyrosine kinase: a new negative regulator in tumor growth and progression.
Cancer Lett. 2006 Sep 28;241(2):159-73. doi: 10.1016/j.canlet.2005.11.004. Epub 2006 Jan 27.

引用本文的文献

2
5
Kidney injury: the spleno-renal connection and splenic tyrosine kinase.肾损伤:脾肾连接与脾酪氨酸激酶
J Nephrol. 2024 Nov;37(8):2151-2160. doi: 10.1007/s40620-024-02121-4. Epub 2024 Oct 10.
6
New insights into SYK targeting in solid tumors.在实体瘤中针对 SYK 的新见解。
Trends Pharmacol Sci. 2024 Oct;45(10):904-918. doi: 10.1016/j.tips.2024.08.006. Epub 2024 Sep 24.

本文引用的文献

2
Getting Syk: spleen tyrosine kinase as a therapeutic target.靶向 Syk:脾酪氨酸激酶作为治疗靶点。
Trends Pharmacol Sci. 2014 Aug;35(8):414-22. doi: 10.1016/j.tips.2014.05.007. Epub 2014 Jun 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验